Navigation Links
Autism in a test tube?
Date:6/14/2010

The first "test tube baby" was born in 1978. With advances in reproductive science, an estimated one percent of all American babies are now born each year through in vitro fertilization (IVF). But IVF and other assisted fertility treatments may be solving one problem by creating another, suggests new evidence from Tel Aviv University.

In a recent study, Dr. Ditza Zachor of Tel Aviv University's Sackler School of Medicine reported a strong link between IVF and mild to moderate cases of autism. Her findings were presented last month at the International Meeting for Autism Research in Philadelphia.

According to her research at the Autism Center at the Assaf Harofeh Medical Center in Israel, which Dr. Zachor directs, 10.5% of 461 children diagnosed with a disorder on the autism spectrum were conceived using IVF, a significantly higher number than the 3.5% autism rate in the general Israeli population.

Other factors in play

While the study doesn't draw any definitive conclusions, it presents some urgent questions, says Dr. Zachor. "It's too early to make a serious deduction based on that evidence alone," she says, citing other birth-related factors in her study, such as low birth rate and prematurity. Dr. Zachor's ongoing research will attempt to separate out these risk factors to come up with more precise numbers for autism and other prenatal conditions in IVF.

The key may be "imprinting," a biochemical procedure during cell division which determines which genes will be selected or "expressed" in the embryo. Research into epigenetics changes in gene expression that occur without a change in the DNA sequence suggest that the malformations may be caused by imprinting abnormalities introduced into the embryo while it's in a test tube environment, says Dr. Zachor. One such disorder linked with IVF appears to be Angelman syndrome.

However, Dr. Zachor does not want to discourage infertile couples from undergoing IVF implantation, which most often results in a healthy child.

Age-appropriate fertility treatments

Dr. Zachor notes that mothers in her study who had IVF tended to be older ― with a median age of 32.6 years. Also significantly, nearly 4% of the children with autism were born prematurely, and about 5% of those had a low birth weight. In the general population, only about 1% of all newborns are delivered with a low birth weight.

Aware of these risks, however, health practitioners may be able to intervene and find ways to avoid the problems, the researcher says. For example, they might recommend that IVF treatments be delayed for a longer period, despite any psychological stress this might cause to would-be parents. Some researchers believe that unassisted fertilization is a better way to avoid negative health effects.

"Many infertile couples choose this procedure, and they need to know whether there is a risk of autism," concludes Dr. Zachor. She stresses, however, that most women who undergo fertility treatments should not be scared away from IVF procedures: the majority of children born using IVF do not have autism, and most children who have autism were not conceived using IVF.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Related biology news :

1. Children with autism dont adapt as readily to unfamiliar faces
2. Rutgers Genetics receives $7.8 million for autism research
3. Simons Foundation awards Emory scientists $3M for autism gene research
4. Largest study to investigate risk factors of autism to begin enrolling families
5. New studies on schizophrenia, depression, trauma and autism highlight annual meeting
6. Study finds first-ever genetic animal model of autism
7. New studies suggest brain overgrowth in 1-year-olds linked to development of autism
8. Recurrent genetic deletion linked to autism
9. Researchers move 2 steps closer to understanding genetic underpinnings of autism
10. Autism Speaks collaborates on grant with the Allen Institute for Brain Science and autism expert
11. Kids with autism may have gene that causes muscle weakness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016  The Office ... today published "Can CT Scans Enhance or Replace ... the potential of supporting or replacing forensic autopsies ... CT scan. In response to recommendations ... is exploring using CT scans as a potential ...
(Date:11/29/2016)... BOSTON , Nov. 29, 2016 BioDirection, ... rapid point-of-care products for the objective detection of concussion ... the company has successfully completed a meeting with the ... company,s Tbit™ blood test Pre-Submission Package. During the meeting ... Tbit™ system as a precursor to commencement of a ...
(Date:11/22/2016)... According to the new market research report "Biometric ... Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, ... is expected to grow from USD 10.74 Billion in 2015 to reach ... and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , ... December 08, 2016 , ... ... FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced ... FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, ... that discovers, develops and plans to commercialize innovative ... shares of common stock were approved for trading ... begin trading on the OTCQX, effective today, under ... for the OTCQX market, companies must meet high ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented ... expansion clinical trial for its lead drug candidate, AC0010, at the World Conference ... was to determine the safety, antitumor activity, and recommended phase II dosage of ...
Breaking Biology Technology: